Hôpitaux Universitaires de Genève (HUG)
Genève, Switzerland
Treatment & access
- Treatments offeredEsketamine nasal spray (Spravato®)
- Access routeCovered by a national programme
- Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
- ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
- Phone+41 22 305 45 11
- Websitehttps://www.hug.ch/specialites-psychiatriques/unite-humeur-anxiete-uha
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Location in Collonge-BelleriveUniversity Hospital Geneva, Palliative medicine department : Clinical trials
- Another programme at this clinicLouise Penzenstadler (Hôpitaux Universitaires de Genève (HUG), Dépt. Psychiatrie) : PAT
- Another programme at this clinicMichel Sabé (Hôpitaux Universitaires de Genève (HUG)) : PAT
- Another programme at this clinicGabriel Thorens (Hôpitaux Universitaires de Genève (HUG)) : PAT
About this provider
The Hôpitaux Universitaires de Genève (HUG) are Geneva's university hospitals and a national reference centre. Depression care is organised through the Mood & Anxiety Unit (Unité Humeur & Anxiété, UHA) of the psychiatric specialties service, which treats unipolar depression, bipolar and anxiety disorders with intensive multidisciplinary follow-up, pharmacological optimisation, individual psychotherapy, psychoeducation and adjuncts such as light therapy and mindfulness-based approaches. HUG's own magazine reports that esketamine nasal spray has been used in its mood disorders unit under close medical supervision for patients not helped by standard treatments.
Services & programs
- Esketamine nasal spray used in the mood disorders unit under close medical supervision (reported by HUG's Pulsations magazine)
- Specialised Mood & Anxiety Unit (UHA) with a unipolar depression program
- Light therapy and mindfulness-based approaches as adjuncts to pharmacological treatment
Common questions
How do I access esketamine (Spravato) treatment here?
Access runs through a psychiatrist. Your treating psychiatrist assesses whether you meet the Swiss criteria for treatment-resistant depression and refers you to the specialised unit.
Is the treatment covered by health insurance?
Spravato is reimbursed by Swiss mandatory health insurance for treatment-resistant depression within the official criteria; the insurer must issue a cost approval (garantie de prise en charge) before the first dose.
5 more verified providers within 50 km
- Carouge · 2 kmLoraine Biéler : PAT
- Lancy · 3 kmBraulio Mora : PAT
- Collonge-Bellerive · 7 kmUniversity Hospital Geneva, Palliative medicine department : Clinical trials
Verification
- License / registryBAG SL Limitatio
- Official registryhttps://www.bag.admin.ch/dam/de/sd-web/uo93E02fcJBh/Liste%20der%20Zentren%20gem%C3%A4ss%20der%20Limitierung%20von%20Spravato_20251001.pdf
- Last verified
Check your fit & enquire
Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Hôpitaux Universitaires de Genève (HUG) only with your explicit consent, and you can download it for yourself either way.
Why enquire via PsyAccess
- Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
- A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
- Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.